complete responders and continuing partial responders were then randomized to receive either non-cross-resistant chemotherapy with doxorubicin , bleomycin , vinblastine , and dtic ( dacarbazine ) ( abvd ) or low-dose radiotherapy to all sites of pretreatment involvement except bone marrow .
C0005740
bleomycin
C0050380
abvd